Ann: Appendix 4C - quarterly, page-69

separately - even if we are a qtr or 2 of the CF target what do you think the FDA approval would do to the share price on TAVR devices with potential market of US$3.5 billion? This is why we should at least buy a trading parcel when she dips like to .235 because we know when they release similar announcements the SP rockets like 50+%

To think WP is doing this now on a performing company with a solid foundation "the Company finalised a corporate restructure, implemented numerous improvement initiatives, reset strategic direction and continued to gain further momentum in the path to profitability." simply not possible when he first joined the board cause it was such a mess!

“As our company story has developed and our brand equity grown during 2017 we have been able to attract higher levels of talent within the field force” said Paterson, which will pay significant dividends during 2018.
This is the beginning of the rash - it will spread quickly and snowball from here imo, as we hit sales in new territories and greater share in established ones.

Overall very happy with the 4c and strategic direction - can't wait to read Infusion business now contributes 2mil